Darcy Parkyn

Darcy Parkyn has a diverse work experience in the pharmaceutical and biotechnology industry. Darcy started their career as a Marketing Manager at Hyperion in 2000 and later worked as an Account Director at Helix Medical Communications from 2003 to 2005. From 2006 to 2007, they served as a Product Manager at Telik BioPharmaceutical, followed by a role as a Product Manager at Jazz Pharmaceuticals from 2007 to 2009. Darcy then worked as a Senior Product Manager in Marketing at Questcor Pharmaceuticals from 2009 to 2011.

In 2011, Darcy joined Medivation as a Sr. Product Manager and later became the Associate Director of XTANDI Oncology Marketing. Darcy held this position until 2014. From 2014 to 2016, they served as the Global Commercial Lead for Breast Cancer at BioMarin Pharmaceutical Inc.

In 2016, Darcy joined Puma Biotechnology, Inc. as the Sr. Director/Head of Marketing, where they played a key role in the launch of NERLYNX. Darcy was later promoted to Vice President, Commercial Breast Cancer and was responsible for Marketing, Nurse Field Team, Access & Reimbursement. Darcy worked at Puma Biotechnology until 2020.

After leaving Puma Biotechnology, Darcy joined Sanofi in 2020 as the Head of Global Breast Cancer Marketing and Global Launch Team Lead. However, due to the failure of a project, they started seeking new employment in 2023.

Currently, Darcy is an Executive Director of Marketing for Breast Cancer Oncology at Stemline Therapeutics, a position they have held since 2023.

Darcy Parkyn attended the University of San Francisco from 2001 to 2003, where they obtained a Master's degree in Public Administration with a focus on Healthcare Systems Administration (MPA, HSA). Additionally, Darcy also pursued a Bachelor's degree in Business Communications (BS) and a Master's degree in Public Health (MPH) with a specialization in Healthcare. The specific years of completion for these degrees are not provided.